Nitric oxide metabolism in mammalian cells: Substrate and inhibitor profiles of a NADPH-cytochrome P450 oxidoreductase-coupled microsomal nitric oxide dioxygenase

被引:32
作者
Hallstrom, CK
Gardner, AM
Gardner, PR
机构
[1] Childrens Hosp, Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA
关键词
nitric oxide dioxygenase; carbon monoxide; cyanide; allicin; imidazole; cytochrome P450; hemoglobin; microsome; free radicals;
D O I
10.1016/j.freeradbiomed.2004.04.031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human intestinal Caco-2 cells metabolize and detoxify NO via a dioxygen- and NADPH-dependent, cyanide- and CO-sensitive pathway that yields nitrate. Enzymes catalyzing NO dioxygenation fractionate with membranes and are enriched in microsomes. Microsomal NO metabolism shows apparent K-M values for NO, O-2, and NADPH of 0.3, 9, and 2 muM, respectively, values similar to those determined for intact or digitonin-permeabilized cells. Similar to cellular NO metabolism, microsomal NO metabolism is superoxide-independent and sensitive to heme-enzyme inhibitors including CO, cyanide, imidazoles, quercetin, and allicin-enriched garlic extract. Selective inhibitors of several cytochrome P450s and heme oxygenase fail to inhibit the activity, indicating limited roles for a subset of microsomal heme enzymes in NO metabolism. Diphenyleneiodonium and cytochrome c(III) inhibit NO metabolism, suggesting a role for the NADPH-cytochrome P450 oxidoreductase (CYPOR). Involvement of CYPOR is demonstrated by the specific inhibition of the NO metabolic activity by inhibitory anti-CYPOR IgG. In toto, the results suggest roles for a microsomal CYPOR-coupled and heme-dependent NO dioxygenase in NO metabolism, detoxification, and signal attenuation in mammalian cells. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:216 / 228
页数:13
相关论文
共 88 条
[1]   Nitric oxide is a physiological substrate for mammalian peroxidases [J].
Abu-Soud, HM ;
Hazen, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (48) :37524-37532
[2]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[3]  
BOULENC X, 1992, J PHARMACOL EXP THER, V263, P1471
[4]   INHIBITION OF CYTOCHROME-P-450 2E1 BY DIALLYL SULFIDE AND ITS METABOLITES [J].
BRADY, JF ;
ISHIZAKI, H ;
FUKUTO, JM ;
LIN, MC ;
FADEL, A ;
GAPAC, JM ;
YANG, CS .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (06) :642-647
[5]   Nitric oxide and mitochondrial respiration [J].
Brown, GC .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1411 (2-3) :351-369
[6]   Nitric oxide, cytochrome-c oxidase and myoglobin [J].
Brunori, M .
TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (01) :21-23
[7]   INDUCTION OF HEME OXYGENASE IN INTESTINAL EPITHELIAL-CELLS - STUDIES IN CACO-2 CELL-CULTURES [J].
CABLE, JW ;
CABLE, EE ;
BONKOVSKY, HL .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1993, 129 (01) :93-98
[8]   Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4 [J].
Chan, WK ;
Delucchi, AB .
LIFE SCIENCES, 2000, 67 (25) :3103-3112
[9]   Differential inhibition of human CYP1A1 and CYP1A2 by quinidine and quinine [J].
Ching, MS ;
Blake, CL ;
Malek, NA ;
Angus, PW ;
Ghabrial, H .
XENOBIOTICA, 2001, 31 (11) :757-767
[10]   Characterization of nitric oxide consumption pathways by normal, chronic granulomatous disease and myeloperoxidase-deficient human neutrophils1 [J].
Clark, SR ;
Coffey, MJ ;
Maclean, RM ;
Collins, PW ;
Lewis, MJ ;
Cross, AR ;
O'Donnell, VB .
JOURNAL OF IMMUNOLOGY, 2002, 169 (10) :5889-5896